These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 16334536)
21. Summarizing disease features over time: II. Variability measures of SLEDAI-2K. Ibañez D; Gladman D; Urowitz M J Rheumatol; 2007 Feb; 34(2):336-40. PubMed ID: 17183620 [TBL] [Abstract][Full Text] [Related]
22. Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. Guzmán J; Cardiel MH; Arce-Salinas A; Sánchez-Guerrero J; Alarcón-Segovia D J Rheumatol; 1992 Oct; 19(10):1551-8. PubMed ID: 1464867 [TBL] [Abstract][Full Text] [Related]
23. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study. Mok CC; Ho LY; Cheung MY; Yu KL; To CH Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189 [TBL] [Abstract][Full Text] [Related]
24. The validity of the inclusion of "lupus headache" in the Systemic Lupus Erythematosus Disease Activity Index. Davey R; Bamford J; Emery P Arthritis Rheum; 2007 Aug; 56(8):2812-3. PubMed ID: 17665430 [No Abstract] [Full Text] [Related]
25. Autoantibody determination in the diagnosis of systemic lupus erythematosus. Kurien BT; Scofield RH Scand J Immunol; 2006 Sep; 64(3):227-35. PubMed ID: 16918691 [TBL] [Abstract][Full Text] [Related]
26. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Brunner HI; Gladman DD; Ibañez D; Urowitz MD; Silverman ED Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232 [TBL] [Abstract][Full Text] [Related]
27. A comparison of prospective and retrospective evaluations of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Bernatsky S; Clarke A; Abrahamowicz M; Neville C; Karp I; Pineau CA J Rheumatol; 2005 May; 32(5):820-3. PubMed ID: 15868615 [TBL] [Abstract][Full Text] [Related]
28. [Indices of disease activity in systemic lupus erythematosus. Review of the literature]. Silvestris N; Lucarelli A; D'Elia F; Tarantino G; Fata L Minerva Med; 1999; 90(5-6):165-74. PubMed ID: 10780191 [TBL] [Abstract][Full Text] [Related]
29. Validity and reliability of lupus activity measures in the routine clinic setting. Petri M; Hellmann D; Hochberg M J Rheumatol; 1992 Jan; 19(1):53-9. PubMed ID: 1556700 [TBL] [Abstract][Full Text] [Related]
30. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations. Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265 [TBL] [Abstract][Full Text] [Related]
31. Systemic lupus erythematosus: a review of the disease and treatment options. Gurevitz SL; Snyder JA; Wessel EK; Frey J; Williamson BA Consult Pharm; 2013 Feb; 28(2):110-21. PubMed ID: 23395811 [TBL] [Abstract][Full Text] [Related]
32. The Systemic Lupus Erythematosus Responder Index (SRI); a new SLE disease activity assessment. Luijten KM; Tekstra J; Bijlsma JW; Bijl M Autoimmun Rev; 2012 Mar; 11(5):326-9. PubMed ID: 21958603 [TBL] [Abstract][Full Text] [Related]
33. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Vilá LM; Alarcón GS; McGwin G; Bastian HM; Fessler BJ; Reveille JD; Arthritis Rheum; 2006 Oct; 55(5):799-806. PubMed ID: 17013840 [TBL] [Abstract][Full Text] [Related]
34. Reliability and validity of the Fatigue Severity Scale in Swedish for patients with systemic lupus erythematosus. Mattsson M; Möller B; Lundberg Ie; Gard G; Boström C Scand J Rheumatol; 2008; 37(4):269-77. PubMed ID: 18612927 [TBL] [Abstract][Full Text] [Related]
35. Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus. Gordon C; Wallace DJ; Shinada S; Kalunian KC; Forbess L; Braunstein GD; Weisman MH Rheumatology (Oxford); 2008 Mar; 47(3):334-8. PubMed ID: 18238794 [TBL] [Abstract][Full Text] [Related]
36. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus. Aggarwal R; Wilke CT; Pickard AS; Vats V; Mikolaitis R; Fogg L; Block JA; Jolly M J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452 [TBL] [Abstract][Full Text] [Related]
37. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease. Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860 [TBL] [Abstract][Full Text] [Related]
38. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus. Petri M; Stohl W; Chatham W; McCune WJ; Chevrier M; Ryel J; Recta V; Zhong J; Freimuth W Arthritis Rheum; 2008 Aug; 58(8):2453-9. PubMed ID: 18668552 [TBL] [Abstract][Full Text] [Related]
39. Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery. Kozora E; Ellison MC; West S Arthritis Rheum; 2006 Aug; 55(4):628-35. PubMed ID: 16874786 [TBL] [Abstract][Full Text] [Related]
40. Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale. Ruiz-Irastorza G; Khamashta MA; Gordon C; Lockshin MD; Johns KR; Sammaritano L; Hughes GR Arthritis Rheum; 2004 Feb; 51(1):78-82. PubMed ID: 14872459 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]